Insider Transactions in Q4 2025 at Immunity Bio, Inc. (IBRX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2025
|
Richard Adcock CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
17,510
-4.75%
|
$17,510
$1.98 P/Share
|
|
Dec 31
2025
|
Richard Adcock CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
34,483
+8.55%
|
-
|
|
Dec 31
2025
|
David C. Sachs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,435
-6.03%
|
$15,435
$1.98 P/Share
|
|
Dec 31
2025
|
David C. Sachs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,397
+10.61%
|
-
|